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Summary
Background Management of pneumonia in many low-income and middle-income countries is based on WHO 
guidelines that classify children according to clinical signs that define thresholds of risk. We aimed to establish 
whether some children categorised as eligible for outpatient treatment might have a risk of death warranting their 
treatment in hospital.
Methods We did a retrospective cohort study of children aged 2–59 months admitted to one of 14 hospitals in Kenya 
with pneumonia between March 1, 2014, and Feb 29, 2016, before revised WHO pneumonia guidelines were adopted 
in the country. We modelled associations with inpatient mortality using logistic regression and calculated absolute 
risks of mortality for presenting clinical features among children who would, as part of revised WHO pneumonia 
guidelines, be eligible for outpatient treatment (non-severe pneumonia).
Findings We assessed 16 162 children who were admitted to hospital in this period. 832 (5%) of 16 031 children died. 
Among groups defined according to new WHO guidelines, 321 (3%) of 11 788 patients with non-severe pneumonia died 
compared with 488 (14%) of 3434 patients with severe pneumonia. Three characteristics were strongly associated with 
death of children retrospectively classified as having non-severe pneumonia: severe pallor (adjusted risk ratio 5·9, 
95% CI 5·1–6·8), mild to moderate pallor (3·4, 3·0–3·8), and weight-for-age Z score (WAZ) less than –3 SD (3·8, 
3·4–4·3). Additional factors that were independently associated with death were: WAZ less than –2 to –3 SD, age 
younger than 12 months, lower chest wall indrawing, respiratory rate of 70 breaths per min or more, female sex, 
admission to hospital in a malaria endemic region, moderate dehydration, and an axillary temperature of 39°C or more.
Interpretation In settings of high mortality, WAZ less than –3 SD or any degree of pallor among children with non-
severe pneumonia was associated with a clinically important risk of death. Our data suggest that admission to hospital 
should not be denied to children with these signs and we urge clinicians to consider these risk factors in addition to 
WHO criteria in their decision making.
Funding Wellcome Trust.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Management of children with pneumonia is based on 
their anticipated risk of poor outcome. In many low-
income and middle-income countries that use WHO 
case management guidelines, hospital admission is 
recommended when a child crosses the threshold from a 
non-severe to a severe pneumonia classification according 
to revised WHO 2013 definitions (table 1).1 Hospital care 
should allow for prompt identification of signs of clinical 
deterioration and timely intervention with appropriate 
investigations, treatment, and supportive care including 
oxygen, fluids, and feeds. Children admitted to hospital 
could also benefit from expert review that can detect other 
causes of illness such as heart disease, which might be 
misdiagnosed as pneumonia by junior clinicians. WHO’s 
revised classification of pneumonia included a change 
from three to two severity strata, such that children with 
lower chest wall indrawing are now classed as having non-
severe pneumonia, whereas a child with this sign would 
have automatically been assigned to the severe category 
under the previous set of criteria.1 Other events that have 
affected the classification of pneumonia include the 
widespread availability of conjugate vaccines against 
Streptococcus pneumoniae and Haemophilus influenzae 
type b (Hib);2 declining prevalence of vertically acquired 
HIV;3 and a technical update of WHO guidelines for the 
management of severe acute malnutrition in infants and 
children, which advises the use of weight-for-height 
Z score (WHZ) and mid-upper-arm circumference to 
replace weight-for-age Z score (WAZ) for the diagnosis of 
severe malnutrition requiring inpatient management.4 
Although studies suggested that the previous WHO 
clinical algorithm performed similarly across different 
geographical locations,5 concerns have been raised 
regarding the applicability of new WHO pneumonia 
guidelines in high mortality settings.6,7
In this study, we assess risk factors for death in children 
treated in hospital with pneumonia in Kenya before 
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implementation of the revised WHO pneumonia 
guidelines. This analysis allows us to explore outcomes 
in a population of children for whom admission to 
hospital would no longer be recommended and 
investigate additional clinical features that might 
improve risk assessment.
Methods
Study design and participants
We did a retrospective cohort study using data from an 
established network of 14 purposely selected public 
hospitals situated in regions of high and low to very low 
malaria transmission in Kenya.8 Inpatient records for all 
children aged 2–59 months admitted to hospital with 
pneumonia between March 1, 2014, and Feb 29, 2016, 
were included. We excluded children with documented 
comorbidities because these are specifically excluded 
from the WHO pneumonia case management algorithm. 
Comorbidities include suspected or confirmed meningitis, 
HIV exposure or infection, severe acute malnutrition 
(typically identified by presence of visible severe wasting 
or oedema, skin changes of kwashiorkor, and mid-upper-
arm circumference less than 11·5 cm or WHZ less than 
–3 SD from WHO reference charts), and chronic 
cardiorespiratory illnesses. Thus, we studied children in 
whom a clinical diagnosis of pneumonia was the primary 
indication for antibiotic therapy. WHO uses the terms 
pneumonia and severe pneumonia to denote groups 
requiring different treat ments. To avoid confusion, we use 
the term pneumonia to refer to all children with a clinical 
diagnosis of pneumonia and the terms non-severe and 
severe pneumonia to refer to children who are 
recommended outpatient and inpatient treatment 
respectively by WHO (table 1).
The participating hospitals are typical of district-level 
health facilities in Kenya and in sub-Saharan Africa, 
where diagnostic capacity is low. Pulse oximetry data 
were not available for over 50% of patients and in 
some hospitals data were not available at all. In line 
with Kenyan policy recommendations, patients with 
uncomplicated pneumonia do not routinely have x-rays. 
In the few cases in which x-rays are done, no structured 
tools exist for data capture.
The Hib and pneumococcal conjugate vaccines were 
introduced to the national routine immunisation schedule 
in 2001 and January, 2011, respectively. Survey data report 
over 80% coverage for three doses of these vaccines 
among children aged 12 months.9 We restricted our 
analysis to children who were born after the introduction 
of Hib and pneumococcal conjugate vaccines.
Data were extracted from patient records devoid of 
names and contact details that could identify individuals 
whose information was collected. Data entry was done 
following patient discharge from hospital or death; thus, 
the exercise did not interfere with routine patient care or 
pose apparent additional risk to patients. Ethics approval 
for the primary study was obtained from the Kenya 
Medical Research Institute (KEMRI) National Ethical 
Review Committee. The Ministry of Health and partici-
pating hospitals gave permission for the study.
Research in context
Evidence before this study
We searched MEDLINE for relevant articles published until 
Jan 16, 2017, on risk factors for community-acquired 
pneumonia in children in low-income and middle-income 
countries by use of the terms “respiratory tract infection” 
[MeSH terms] OR “pneumonia” AND “(child* OR paediatric OR 
pediatric)” AND (“mortality OR death”). The search was not 
restricted by date or language. We retrieved a systematic review 
of 77 observational studies (198 359 children) on risk factors for 
death from acute lower respiratory infections in children in 
low-income and middle-income countries.
Added value of this study
Published evidence on risk factors for community-acquired 
childhood pneumonia comes from studies almost entirely 
done in the pre-pneumococcal vaccine period. The clinical 
cause of childhood pneumonia is believed to be changing with 
increasingly high coverage of conjugate vaccines targeting 
previously dominant causes of pneumonia. This study—the 
largest published individual analysis of risk factors for 
mortality among children admitted to hospital with 
pneumonia—presents findings from a high mortality setting 
with a high prevalence of comorbidity. We also present unique 
data on risk of death for subpopulations of children classified 
as having non-severe pneumonia, who, under existing 
guidance, might have a level of risk warranting inpatient care.
Implications of all the available evidence
The risk factors for pneumonia mortality include severe 
pneumonia (previously very severe pneumonia), low 
weight-for-age Z score (WAZ), female sex, age younger than 
12 months, Pneumocystis carinii infection, HIV infection, young 
maternal age, low maternal education, low socioeconomic 
status, secondhand cigarette smoke exposure, indoor air 
pollution, childhood immunisation status not up to date, 
non-attendance of antenatal care, and from our study, mild and 
moderate pallor, respiratory rate of 70 breaths per min or more, 
admission to hospital in a malaria endemic region, moderate 
dehydration, and an axillary temperature of 39°C or above. 
The risk of death for children classified as having non-severe 
pneumonia with mild to moderate pallor, severe pallor, or low 
WAZ is similar to that observed for children with WHO-defined 
severe pneumonia. In high mortality settings, a need exists to 
re-examine criteria for admission, and clinicians should treat 
the WHO severe category as but one factor to consider in clinical 
decision making.
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Procedures
Methods of collection and cleaning of data in the clinical 
information network are reported in detail elsewhere.10 
Clinical data for children admitted to hospitals within the 
network are captured through structured Paediatric 
Admission Record forms,11 approved by the Ministry of 
Health, that prompt the clinician with a checklist of fields 
including patient biodata, information gathered during 
clinical assessment, admission and discharge diagnoses, 
treatments, and outcome (survival or death). The network 
supports one data clerk in each hospital to extract data 
from medical records, nursing charts, treatment charts, 
and available laboratory reports each day as children are 
discharged. Data are abstracted from inpatient records 
into the primary data collection tool developed in 
Research Electronic Data Capture (REDCap)12 with error 
checks at point of entry by automated daily review, and 
with regular external data quality assurance.10
Statistical analysis
Categorical data were tabulated and summarised as 
proportions, whereas continuous variables were reported 
as mean (SD) or median (IQR) as appropriate. Univariate 
associations with mortality were calculated for demo-
graphic and clinical characteristics with at least 50% 
of data available. These variables were subsequently 
considered for inclusion in multivariable logistic re-
gression models restricted to complete cases. Patients’ age 
and sex were included in multivariable models a priori. 
Hospital identity was included in models as a random 
effect, whereas location was grouped as a binary variable 
on the basis of high versus low prevalence of malaria and 
included as a fixed effect. Other patient characteristics 
associated with mortality and a p value of less than 0·2 in 
univariate analyses were added sequentially, beginning 
with characteristics with the strongest association from 
univariate models. Likelihood ratio tests were done on 
addition of each variable to identify the variables to be 
retained (Model 1). Sub sequently, multiple imputation by 
chained equations (generating ten imputed datasets) was 
done under missing at random assumption.13 The 
robustness of this assumption was assessed in sensi-
tivity analyses under the assumption of missingness not 
at random through use of pattern mixture models 
(appendix).14 To enhance efficiency and minimise bias in 
the imputation procedure, we included variables for which 
documentation was complete or almost complete even if 
they were irrelevant to substantive analysis.15 Covariates 
included in Model 1 were then analysed in models 
including all patients (Model 2) and restricted to non-
severe cases (Model 3) through use of imputed datasets. 
For ease of clinical interpretation, particularly where risk 
factors were associated with high mortality, we converted 
odds ratios from logistic regression models to risk ratios.16 
Accuracy of the three models was analysed by computing 
areas under the receiver operating characteristic (ROC) 
curve. For children with non-severe pneumonia, we 
calculated crude absolute risks of mortality by individual 
risk factor status as proportions with associated binomial 
exact 95% CIs. Subdivision of patients with non-severe 
pneumonia into groups by status of risk factor (with or 
without risk factor of interest) enabled us to compare risks 
of death between patients with and patients without the 
risk factor, and between those with non-severe pneumonia 
and an individual risk factor and patients with WHO-
defined severe pneumonia. No allowance was made for 
multiple hypothesis testing. Results showing statistical 
significance close to p=0·05 should therefore be 
interpreted with caution. We analysed data with STATA 
version 12.0. The reporting of this study conforms to 
STROBE recommendations.17
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
Clinical signs Recommended setting for management and antibiotic treatment
Severe 
pneumonia
Any one of: oxygen saturation <90%, central cyanosis, severe respiratory 
distress, inability to drink or breastfeed or vomiting everything, altered 
consciousness, and convulsions
Inpatient management; benzyl penicillin or ampicillin, and gentamicin; 
add high dose co-trimoxazole for all infants exposed to or infected 
with HIV
Non-severe 
pneumonia
Lower chest wall indrawing or fast breathing (respiratory rate ≥50 breaths 
per min if aged 2–11 months; ≥40 breaths per min if aged 12–59 months), 
and without signs of severe pneumonia
Outpatient management; oral amoxicillin; for infants with indrawing 
exposed to or infected with HIV, treat as severe pneumonia
Adapted with permission from WHO.1
Table 1: WHO 2013 guidelines for management of children aged 2–59 months with cough, difficulty breathing, or both
See Online for appendix
Figure 1: Study profile
21 832 patients aged 2–59 months and admitted to hospital 
 with pneumonia between March 1, 2014, and 
 Feb 29, 2016
16 162 included in analysis
 12 025 non-severe pneumonia
 3468 severe pneumonia
 669 unclassified
5670 excluded
 3287 severe acute malnutrition
 1180 meningitis
 134 exposed to or infected with HIV
 220 chronic cardiorespiratory illness
 849 born before November, 2010
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the report. The corresponding author had full access to 
all data and had final responsibility for the decision to 
submit for publication.
Results
21 832 records were available for children aged 
2–59 months admitted to any one of 14 hospitals with a 
diagnosis of pneumonia between March 1, 2014, and 
Feb 29, 2016. Records for 5875 children with admission 
diagnoses that would exclude them from the WHO 
pneumonia case management algorithm were also 
excluded from the study. Children born before 
November, 2010, were excluded in keeping with our aim 
to study children in the post-vaccination era; therefore, 
analysis included 16 162 children (figure 1).
The median age of the study population was 12 months 
(IQR 7–24) (table 2). Of 16 127 children for whom sex 
was documented, 7180 (45%) were girls. 5313 (33%) of 
16 162 patients were admitted to hospitals in malaria 
endemic regions of Kenya. By use of documented clinical 
diagnosis and available information on clinical signs, we 
assigned pneumonia severity categories to patients on 
the basis of the WHO 2013 classification (table 1).1 
12 025 (74%) of 16 162 patients had non-severe pneumonia 
and 3468 (22%) of 16 162 had severe pneumonia. 669 (4%) 
of 16 162 children had inadequate documentation on key 
clinical signs required to assign their category of severity. 
Lower chest wall indrawing was present in 7514 (61%) of 
12 323 children, of whom 5320 (71%) were classified with 
non-severe pneumonia. We excluded children diagnosed 
with severe acute malnutrition at admission from 
analysis but calculated WAZ using WHO child growth 
standards18 for children remaining in the cohort because 
data for these two variables were complete for most 
patients studied. Although low WAZ might be due to 
stunting (chronic malnutrition), overlap exists across the 
categories of severity for mid-upper-arm circumference, 
WHZ, and WAZ.19 Each child was assigned to a 
nutritional category: normal WAZ (≥–2 SD), low WAZ 
(<–2 to –3), and very low WAZ (<–3). Data to calculate 
WAZ were available for 15 330 children of whom 
12 324 (80%) had a normal score, 1861 (12%) had a low 
score, and 1145 (8%) had a very low score—none of the 
children were assigned a diagnosis of severe acute 
malnutrition by the admitting clinician. Pallor was 
present in 1257 (10%) of 12 231 children with available 
data for the sign (table 2).
Documented outcomes were available for 16 031 (99%) of 
16 162 children, and of those, 832 died (5·2%). 488 (14·2%) 
of 3434 children with severe pneumonia died compared 
with 322 (2·7%) of 11 930 children within the non-severe 
category (risk ratio [RR] 5·3, 95% CI 4·6–6·0) (table 3). 
Mortality was higher in children younger than 12 months 
than those aged 12–59 months (RR 3·0, 2·6–3·4). 
Admission to hospitals in regions of high malaria 
prevalence was associated with increased risk of death 
(RR 1·3, 95% CI 1·2–1·5). Mortality also increased with 
decreasing WAZ. Among children with WAZ of –2 SD or 
more, mortality was 3·8% whereas 7·6% of children with 
WAZ less than –2 SD to –3 SD and 11·2% of those with 
scores less than –3 SD died (score test for linear 
trend p<0·0001). Similarly, mortality increased pro-
portionate to increasing severity of pallor and dehydration. 
Other characteristics that were associated with increased 
mortality were elevated respiratory rate (≥70 breaths 
per min), lower chest wall indrawing, axillary temperature 
(≥39°C), and female sex. Immunisation status was only 
weakly associated with mortality (table 3).
Adjusted models included all variables analysed 
in univariate analyses except immunisation status. 
Parameter estimates from Model 1 (complete case 
analysis) were similar to those obtained in analyses in 
which missing data were imputed (table 4). In the full 
model in which imputed data were used (Model 2), severe 
pneumonia (vs non-severe pneumonia) was independently 
associated with high mortality (adjusted risk ratio 
[aRR] 3·9, 95% CI 3·7–4·1). Other characteristics that 
were strongly associated with mortality (at least double 
Frequency or 
median
Number of 
patients
Age (months) 12 (7–22) 16 162
Female 7180 (45%) 16 127
Hospital location: high malaria 
prevalence*
5313 (33%) 16 162
Immunisation status not up to date† 373 (4%) 9135
Pneumonia severity ·· 16 162
Non-severe 12 025 (74%) ··
Severe 3468 (21%) ··
Unclassified 669 (4%) ··
Respiratory rate (breaths per min) ·· 10 992
2–11 months 56 (45–64) 5115
12–59 months 48 (40–60) 5877
Lower chest wall indrawing present 7514 (61%) 12 323
High fever (axillary temperature ≥39°C) 2049 (18%) 11 706
WAZ ·· 15 330
≥–2 SD (normal) 12 324 (80%) ··
<–2 SD (low) 1861 (12%) ··
<–3 SD (very low) 1145 (7%) ··
Pallor ·· 12 231
Absent 10 974 (90%) ··
Mild to moderate 874 (7%) ··
Severe 383 (3%) ··
Dehydration ·· 16 091
Absent or no dehydration 14 638 (91%) ··
Some dehydration 902 (6%) ··
Severe dehydration 551 (3%) ··
Data are median (IQR) or n (%). WAZ=weight-for-age Z score. *Versus low to very 
low malaria prevalence. †Diphtheria, pertussis, tetanus, Haemophilus influenzae 
type b, hepatitis B, and pneumococcal vaccines: fewer than three doses at 
3 months of age or older or fewer than two doses at 2 months of age or older.
Table 2: Demographic and clinical characteristics of the study participants
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the risk of death) were mild to moderate (aRR 3·4, 95% CI 
3·2–3·6) and severe (5·6, 5·1–6·1) pallor, lower chest 
wall indrawing (2·0, 1·8–2·1), WAZ less than –3 SD (2·1, 
1·9–2·2), infants versus children aged 12–59 months 
(2·5, 2·4–2·7), and children with severe dehydration 
(2·2, 2·0–2·2) or some dehydration (2·2, 2·0–2·4) versus 
no dehydration. Female sex, admission to hospital in a 
region of high malaria prevalence, elevated axillary 
temperature (≥39°C) or respiratory rate (≥70 breaths 
per min), and WAZ –2 to –3 SD were all also associated 
with increased mortality (aRR 1·3–1·9).
We further examined the independent associations for 
mortality within the category of non-severe pneumonia 
(for whom outpatient management is recommended) 
through use of imputed datasets (Model 3). The findings 
of this analysis were consistent with models using the 
full datasets (table 4). Areas under the ROC curve for 
each model showed good accuracy (0·8565, 0·8456, and 
0·8115 for model 1, 2, and 3 respectively). Plots from the 
ROC analysis are provided in the appendix.
In subgroup analyses confined to children with non-
severe pneumonia, estimated mortality of children with 
WAZ less than –3 SD (7·5%, 95% CI 4·9–11·8), mild to 
moderate pallor (7·8%, 5·1–11·4), and severe pallor 
(11·2%, 7·7–15·6) was similar to mortality observed 
in children with severe pneumonia (upper bound 
of 95% CI >10%). Risk of death for children with 
non-severe pneumonia and one risk factor—infants, 
admission to hospital in a malaria endemic region, 
respiratory rate of 70 breaths per min or higher, 
WAZ less than –2 to –3 SD, or moderate dehydration—
exceeded the overall risk among children with non-
severe pneumonia (lower bound of 95% CI higher than 
the upper bound for all non-severe pneumonia cases). 
The absolute risk of mortality among children with 
non-severe pneumonia and lower chest wall indrawing 
(used to denote severe illness requiring admission to 
hospital in the previous WHO guideline) was 3·2% 
(95% CI 2·7–3·7). 9968 (83%) of 12 025 children with 
non-severe pneumonia had at least one risk factor that 
increased their mortality beyond the upper bound of 
95% CI of overall mortality for non-severe pneumonia. 
Conversely, only one (0·2%, 95% CI 0·004–0·9) of 
595 children with non-severe pneumonia and without 
any of the risk factors analysed died (figure 2; table 4).
Discussion
We sought to determine the risk factors for pneumonia 
mortality among children admitted to hospital in settings 
with high prevalence of comorbidities. By contrast with 
previous studies in highly controlled research environ-
ments,20 we proposed to study children who were managed 
in real-life settings in which most studies on guideline 
adherence suggest only partial compliance.21–24 This study 
represents the largest published individual analysis of risk 
factors for mor tality among children with WHO-defined 
non-severe pneu monia. Pneumonia mortality in our 
study (5·2%), in a period after the introduction of 
conjugate vaccines, was higher than mortality reported in 
a previous systematic review25 that included infants 
younger than 2 months of age (pooled case fatality 3·9%). 
However, our results are similar to those from a secondary 
analysis of data from a clinical trial26 done in eight Kenyan 
hospitals before the introduction of the pneumococcal 
vaccine (overall pneumonia mortality 5·4%). The 
difference observed between the systematic review and 
clinical trial26 and our study might reflect higher baseline 
risk in sub-Saharan Africa, or selection of children with 
Number of deaths/
number of patients
Mortality (%) RR (95% CI) p value* Ptrend
Pneumonia classification
Non-severe 322/11 930 2·7% 1 ·· ··
Severe 488/3434 14·2% 5·3 (4·6–6·0) <0·0001 ··
Unclassified 22/667 3·3% 1·2 (0·8–1·9) <0·0001 ··
Age
12–59 months 228/8471 2·7% 1 ·· ··
2–11 months 604/7560 8·0% 3·0 (2·6–3·4) <0·0001 ··
Sex
Male 380/8767 4·3% 1 ·· ··
Female 447/7115 6·3% 1·4 (1·3–1·7) <0·0001 ··
Malaria prevalence
Low 504/10 747 4·7% 1 ·· ··
High 328/5284 6·2% 1·3 (1·2–1·5) <0·0001 ··
Immunisation status
Up to date 404/8683 4·7% 1 ·· ··
Not up to date 27/365 7·4% 1·6 (1·1–2·3) 0·04 ··
Respiratory rate
<70 breaths per min 125/1254 4·1% 1 ·· ··
≥70 breaths per min 394/9657 10·0% 2·4 (2·0–3·0) <0·0001 ··
Lower chest wall indrawing
Absent 132/4770 2·8% 1 ·· ··
Present 468/7455 6·3% 2·3 (1·9–2·7) <0·0001 ··
Axillary temperature
<39°C 394/9587 4·1% 1 ·· ··
≥39°C 158/2026 7·8% 1·9 (1·6–2·3) <0·0001 ··
WAZ
≥–2 SD 469/12 235 3·8% 1 ·· <0·0001
<–2 to –3 SD 140/1843 7·6% 2·0 (1·6–2·3) <0·0001 ··
<–3 SD 127/1134 11·2% 2·9 (2·4–3·4) <0·0001 ··
Pallor
Absent 396/10 888 3·6% 1 ·· <0·0001
Mild to moderate 127/865 14·7% 4·0 (3·3–4·7) <0·0001 ··
Severe 68/382 17·8% 4·8 (3·8–6·0) <0·0001 ··
Dehydration
Absent 635/14526 4·4% 1 ·· <0·0001
Some 59/892 6·6% 1·5 (1·2–1·9) <0·0001 ··
Severe 126/543 23·2% 5·2 (4·4–6·0) <0·0001 ··
Weight-for-age Z score (WAZ) based on WHO reference growth standards. Immunisation status omitted in 
multivariable models. RR=risk ratio. *p values derived from χ² test.
Table 3: Univariate associations for mortality among all children admitted to hospital with pneumonia
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low risk in prospective studies included in the systematic 
review. In our study, less than 0·5% of children with non-
severe pneumonia and without any of the risk factors 
studied died. Mortality among non-severe cases (as 
defined by WHO) in our study was also higher (2·7%) 
than other studies that report mortality rates less than 1% 
for this category of patients.20
WHO guidelines recognise severe malnutrition defined 
by WHZ or mid-upper-arm circumference as a risk factor 
for mortality, warranting inpatient care when present in 
association with pneumonia. The use of WAZ is no longer 
recommended as a screening approach to identify severe 
acute malnutrition.4 We observed a high prevalence of low 
to very low WAZ (almost 20% of the study population), 
even after exclusion of cases of severe acute malnutrition 
were identified by the admitting clinician on the basis of 
mid upper-arm-circumference, WHZ, visible severe 
wasting, or oedema due to kwashiorkor. Children with 
non-severe pneumonia and WAZ less than –3 SD and 
without severe acute malnutrition had a risk of death 
almost three times higher than patients with non-severe 
pneumonia. Increased risk of death among children with 
poor nutritional status is widely thought to be linked to 
deficiencies in immune function.27–29 Consistent with our 
findings, a systematic review30 of children with pneumonia 
and malnutrition (defined by use of WAZ or WHZ) 
reported invariably high risks of death for both moderate 
or severe forms of malnutrition in all 16 studies included.
The presence of pallor, even when classified as mild or 
moderate, was also strongly associated with mortality 
across all our analyses. Severe pallor is commonly used 
as a clinical marker for anaemia in settings where 
laboratory diagnostics are unavailable, with sensitivity 
and specificity above 80% for children with packed cell 
volumes less than 15%.31,32 Anaemia is a common 
presenting feature in sub-Saharan African children, 
manifesting acutely in conditions such as malaria and 
chronically because of inadequate nutritional iron intake 
or helminthic infestation. Severe anaemia has been 
associated with increased mortality in previous studies of 
children with pneumonia;33–35 our study presents new 
evidence showing risk for mild forms.
These findings have important implications for the 
WHO policy advocating for outpatient treatment for all 
but the children with a small set of clinical signs that 
define severe pneumonia. Although severe pallor would 
generally warrant admission to hospital, the existing 
recommendations for case management do not consider 
very low WAZ or mild to moderate pallor as important 
risk factors. Thus 1272 (11%) of 12 025 children defined as 
having non-severe pneumonia in this study with either 
of these two risk factors would be expected to be managed 
at home.
A large subpopulation of children had at least one risk 
factor that was independently associated with mortality, 
and absolute risks of death higher than the upper 
confidence limit of that for all non-severe pneumonia 
cases, but below that for severe pneumonia (mortality 
between 3% and 10%). The characteristics falling in this 
category were age younger than 12 months, admission to 
hospital in a location with high malaria prevalence, 
elevated respiratory rate (≥70 breaths per min), WAZ less 
than –2 to –3 SD, lower chest wall indrawing, and 
moderate dehydration. Our analysis concurs with the 
findings of a systematic review36 of risk factors for 
mortality in children with pneumonia (almost entirely 
Model 1: complete 
case analysis (all 
pneumonia cases)
Model 2: multiple 
imputation analysis 
(all pneumonia cases)
Model 3: multiple 
imputation analysis 
(non-severe pneumonia 
only)
Adjusted 
RR*
95% CI Adjusted 
RR*
95% CI Adjusted RR* 95% CI
Pneumonia classification
Non-severe 1 (ref) ·· 1 (ref) ·· ·· ··
Severe 4·2 (3·4–5·2) 3·9 (3·7–4·1) ·· ··
Age
12–59 months 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
2–11 months 2·7 (2·2–3·4) 2·5 (2·4–2·7) 2·8 (2·6–3·1)
Sex
Male 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Female 1·6 (1·3–1·9) 1·5 (1·4–1·6) 1·4 (1·3–1·6)
Malaria prevalence
Low 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
High 1·3 (1·1–1·7) 1·3 (1·2–1·4) 1·6 (1·4–1·7)
Respiratory rate
<70 breaths per min 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
≥70 breaths per min 1·8 (1·4–2·3) 1·8 (1·7–1·9) 2·3 (2·1–2·6)
Lower chest wall indrawing
Absent 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Present 1·8 (1·4–2·4) 2·0 (1·8–2·1) 2·5 (2·2–2·7)
Axillary temperature
<39ºC 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
≥39ºC 1·9 (1·5–2·3) 1·8 (1·7–1·9) 1·9 (1·7–2·1)
WAZ
≥–2 SD 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
<–2 to –3 SD 1·8 (1·4–2·4) 1·90 (1·8–2·0) 2·4 (2·2–2·7)
<–3 SD 2·1 (1·6–2·9) 2·05 (1·9–2·2) 3·8 (3·4–4·3)
Pallor
Absent 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Mild to moderate 3·5 (2·7–4·5) 3·38 (3·2–3·6) 3·4 (3·0–3·8)
Severe 6·1 (4·3–8·7) 5·58 (5·1–6·1) 5·9 (5·1–6·8)
Dehydration
Absent 1 (ref) ·· 1 (ref) ·· 1 (ref) ··
Some 2·5 (1·7–3·6) 2·17 (2·0–2·4) 2·2 (2·0–2·6)
Severe 2·3 (1·6–3·1) 2·21 (2·0–2·4) No 
observations
··
Weight-for-age Z score (WAZ) classification based on WHO reference growth standards. RR=risk ratio. *Models adjusted for 
age, sex (a priori covariates), hospital location (fixed effect), immunisation status, WHO pneumonia category (except where 
only patients with non-severe pneumonia are analysed), respiratory rate, temperature, WAZ, pallor, and dehydration.
Table 4: Multivariable models for risk factors for mortality—complete case analysis and multiple 
imputation analyses (all pneumonia cases and non-severe pneumonia only)
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done in the pre-pneumococcal vaccine period). In this 
review36 that included over 135 000 children from sub-
Saharan Africa, the risk factors for mortality in common 
with our study were low WAZ, female sex, and age 
younger than 12 months. Infants, who constituted half the 
population in our study and had mortality three times 
greater than children aged 12–59 months, are also not 
assigned priority under the WHO guidelines despite 
urgent recommendations for review of the guidelines 
after previous studies.37,38
WHO modified the pneumonia case management 
algorithm to define only two levels of severity in place of 
the previous three. This recommendation might simplify 
training of health workers at the primary care and 
community level by reducing decision making to whether 
a child requires inpatient or outpatient care. The 
downgrading of lower chest wall indrawing, previously 
a sign defining the need for admission, has been 
challenged in settings of high mortality,7 where, among 
other signs, it is associated with fatal pneumonia.39 Our 
analyses show the presence at hospital level of many 
children with signs of unrecognised intermediate 
severity, including lower chest wall indrawing. At least in 
Kenya, such children appear to have an in-hospital 
mortality of at least 3%.
Although we highlight associations with mortality in 
this article, identification of characteristics that might 
optimise decision making on admission (linked to risk of 
poor outcome) while being parsimonious to promote 
simplicity will require additional analyses. In a related 
article,40 we attempt to use machine learning modelling 
techniques to rank risk factors for pneumonia mortality 
and use decision curve analysis to explore potential net 
benefit of the use of highest-ranking risk factors in the 
decision to admit non-severe pneumonia cases.
Although patients with severe pneumonia were 
largely prescribed guideline-recommended broad-
spectrum antibiotics on admission (unpublished), 
mortality was more than five times higher than that 
observed for the non-severe category. The high mortality 
in this group might suggest late clinical presentation 
(justifying the need for interventions targeting improved 
care-seeking or referral structures), or inadequacy of 
existing treatments, suggesting the need for research to 
explore alternative antibiotic regimens or interventions 
to improve supportive care in settings with scarce 
resources. Supportive care might include improved use 
of routine pulse oximetry, use of reliable oxygen 
supplies, appropriate administration of fluids and 
feeding, and optimisation of nursing care.41–43
Figure 2: Estimated risks of death among patients with non-severe pneumonia by risk factor status
WAZ=weight-for-age Z score. *Excludes patients aged 2–11 months, girls, treatment in hospital in area with high prevalence of malaria, immunisations not up to date, 
respiratory rate ≥70 breaths per min, chest indrawing present, axillary temperature ≥39ºC, WAZ <–2 SD, mild to moderate or severe pallor, or moderate dehydration. 
Mortality 
(95% CI)
All pneumonia
All non-severe
Non-severe, no risk factors*
Age 12–59 months
Age 2–11 months
Male sex
Female sex
Low malaria prevalence
High malaria prevalence
Immunisation up to date
Immunisation not up to date
Respiratory rate <70 breaths per min
Respiratory rate ≥70 breaths per min
Chest indrawing absent
Chest indrawing present
Axillary temperature <39ºC
Axillary temperature ≥39ºC
WAZ ≥–2 SD
WAZ <–2 to –3 SD
WAZ <–3 SD
Pallor absent
Mild to moderate pallor
Severe pallor
Dehydration absent
Moderate dehydration
 5·2% (4·9–5·5)
 2·7% (2·4–3·0)
 0·2% (0·0–0·9)
 1·5% (1·2–1·8)
 4·2% (3·7–4·8)
 2·2% (1·9–2·6)
 3·3% (2·8–3·8)
 2·2% (1·9–2·5)
 3·8% (3·2–4·4)
 2·3% (1·9–2·7)
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The large sample size taken from multiple hospitals 
across the country resulted in precise estimates that are 
broadly representative of the population of children 
admitted to hospital with pneumonia in many district 
hospitals in sub-Saharan Africa. The collection of data 
covering 2 years further enhanced representativeness 
through elimination of seasonal bias—an important 
consideration in studies on acute respiratory infections 
in children.44 Our analysis is based on clinical features 
recorded by many junior clinicians providing routine 
care; therefore, the interpretation of clinical signs is 
likely to vary. However, non-differential misclassification 
resulting from variations in interpretation of signs would 
be expected to increase random error and reduce the 
precision of risk estimates. Arguably, inclusion of data 
captured by many clinicians in routine practice increases 
the generalisability of our findings.
Analysis is based on documentation of clinical 
assessments and subsequent data entry. This method has 
the potential for selection bias arising from misplaced 
patient records not included in the analysis. However, 
considerable effort was made to ensure comprehensive 
sampling through data entry immediately after the end of 
the inpatient stay with regular comparisons of clinical 
records retrieved against hospital admission registers. 
Rigorous training and close supervision of data clerks, 
use of structured patient admission forms with feedback 
on their completeness, and dissemination of standard 
clinical guidelines to health workers at the study hospitals 
improved the quality of data collected.45 We also applied 
multiple imputation to maximise the use of available data 
and did sensitivity analyses that supported the assumption 
that missingness was not associated with severity.
Inadequate individual data on malaria status led us to 
use hospital location (high vs low to very low malaria 
endemicity) as a crude proxy for this diagnosis. Overlap 
in clinical presentation of malaria from pneumonia46–48 
might have undermined the validity of risk factor analyses 
outside high malaria endemic settings. To explore this 
possibility, we did subanalyses restricted to patients from 
very low malaria endemic sites (unpublished), which 
yielded parameter estimates that were consistent with 
those obtained through use of the full dataset including 
statistically significant (p<0·0001) associations with 
mortality for high fever and pallor (two signs common 
in malaria).
Systematic reviews have shown substantially lower 
risks of mortality among immunised children than 
unimmunised children;30,36 this association was not 
apparent in our study. A possible explanation for this 
absence might be errors of misclassification perhaps 
attributable to unreliable caregiver-reported data on 
immunisation status. Inclusion of data on oxygen 
saturation would have been potentially useful for further 
definition of risk; however, pulse oximetry is still not 
commonly available in the study hospitals. Confirmation 
of the extent to which treatments prescribed such 
as antibiotics, oxygen, and fluids were received was 
not possible.
We were unable to collect information on clinical 
characteristics and outcomes of children with pneumonia 
managed as outpatients. These data are not available from 
routine settings in hospitals that contributed data to this 
analysis, nor any other setting in sub-Saharan Africa. 
Unobserved factors might have prompted admission of 
some children—ie, clinicians might have been res-
ponding to so-called gut feeling about severity.49 Such 
clinical decisions might have resulted in a higher mortality 
among children admitted to hospital with a given profile 
of specified risk factors than among children not admitted 
to hospital with those same risk factors. However, even if 
risk of death among patients admitted to hospital with 
risk factors was higher than the risk among patients not 
admitted to hospital with the same risk factors, the 
potential for adverse consequences of implementation of 
the WHO guidelines in a country such as Kenya cannot be 
ignored. Thus, discharging of children at high risk would 
probably result in worse outcomes if hospital admission is 
effective. The only reason for promulgation of a guideline 
is to change practice, and in this case, that would mean 
admission of a reduced proportion of patients shown by 
our study to have a high risk of death.
Most children admitted to hospital in a period 
immediately preceding the implementation of policy 
guidelines that would classify them as having non-severe 
pneumonia presented with at least one factor associated 
with a risk of inpatient death above 3%. Among these 
children, mortality was substantially higher for those 
presenting with WAZ less than –3 SD or pallor (both mild 
to moderate and severe) than those without these risk 
factors. Additionally, infants, admission to hospital in a 
location with high malaria prevalence, WAZ less than –2 to 
–3 SD, females, elevated respiratory rate (≥70 breaths per 
min) or axillary temperature of 39°C or above, lower chest 
wall indrawing, and some dehydration were independently 
associated with increased mortality. Our study therefore 
identifies subgroups of patients at risk for future 
intervention studies to refine pneumonia case management 
among inpatients and outpatients. Our findings suggest 
that presence of WAZ less than –3 SD or any degree of 
pallor among children with WHO-defined non-severe 
pneumonia should be considered alongside the WHO 
criteria for admission care in contemporary African 
populations—a finding warranting further study. Although 
this outcome does not constitute formal evidence that 
making use of these factors would save lives, these results 
imply a risk of offering outpatient treatment to specific 
patient subgroups with non-trivial risks of mortality, and 
provide a foundation for future work to derive a simple risk 
score for implementation in clinical settings where WHO 
case management guidelines are in use.
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